• OUTLOOK ARENA
  • VIEWS ON NEWS
  • MARCH 31, 2001

Sectoral funds weekly roundup

The last two days of the week took the sheen off the bourses, which they had gained during the first three days. The Sensex declined by 0.9% to close at 3,604 points whereas the S&P CNX Nifty fell by 1.04% to close at 1,149 points.

Open-ended, IT Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Inception
K P Internet Opport.(Gr) 5.2 2.8% -15.3% -45.5% -45.5%
UTI Sector- Software 9.0 2.3% -25.9% -74.8% -11.3%
K P Infotech (Gr) 15.3 1.9% -25.9% -66.9% 56.3%
Sun F&C Emerg Tech (Gr) 4.0 1.3% -23.6% -54.3% -53.9%
Chola Freedom Tech (Cum) 9.8 1.0% -15.6% -53.4% -1.2%
Pru ICICI Tech. (Gr) 3.5 0.6% -19.5% -64.6% -63.2%
K Tech 3.7 0.5% -25.9% 0.0% -52.8%
Alliance New Millenn (Gr) 5.1 0.0% -21.2% -65.5% -63.3%
DSP ML Tech.com (Gr) 4.3 -0.2% -27.3% 0.0% -50.1%
Magnum Sector Funds-IT 7.7 -0.8% -26.3% -74.2% 11.7%
Returns over 12 months are annualized

After a long time there is some ray of hope in the Information technology (IT) sector as few funds were able to churn in minimal returns. However IT major Infosys remained the loser on the Sensex. Stocks like NIIT and Satyam Computers were stern and settled down as gainers. There may be more movement in IT stocks as some key companies are expected to announce their results during the coming weeks.

Open-ended, Pharma Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Inception
Magnum Sector Funds-Pharma 9.0 -0.4% -8.7% -15.2% -6.2%
K P Pharma (Gr) 9.0 -0.7% -8.2% -14.4% -1.7%
UTI Sector-Pharma 10.2 -1.2% -7.7% -12.3% -8.4%
Returns over 12 months are annualized

The NAVs (net asset values) of Pharma funds were hit during the week as Fulford declared a poor result and pharma stocks saw some selling. Dr. Reddy’s and Cipla were the marginal gainers whereas Glaxo and Ranbaxy were the key losers.

Open-ended, FMCG Schemes NAV
(Rs)
Last
week
Last
month
Last
year
Inception
Pru ICICI FMCG (Gr) 9.2 1.5% -6.8% -16.0% -5.8%
K P FMCG (Gr) 10.9 1.1% -6.4% -19.0% 6.0%
Magnum Sector Funds-FMCG 7.0 1.0% -10.7% -34.0% -18.1%
Returns over 12 months are annualized

The fast moving consumer goods (FMCG) sector saw some buoyancy as Indian Shaving declared decent results. FMCG major Hindustan lever remained the gainer on the bourses whereas Colgate and Nestle were the losers. In the week ahead one may expect volumes to dwindle even further following stockbroker Mr. Ketan Parekh’s arrest. Next week also brings up some public holidays. This will not help the volumes either.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407